Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Enhancement Combined With Omega-3 Fatty Acids for the Treatment of Early Dementia

NCT05181189 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT05181189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Enhancement Combined With Omega-3 Fatty Acids for the Treatment of Early Dementia
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
March 31, 2028
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, omega 3 fatty acids